OEC year-end numbers dip

Article

Mobile C-arm manufacturer OEC Medical Systems last week postedlower income and revenues for its 1994 fiscal year (end-December).The Salt Lake City company said market pressures and delays inshipping its new Series 9600 mobile C-arm may have affected

Mobile C-arm manufacturer OEC Medical Systems last week postedlower income and revenues for its 1994 fiscal year (end-December).The Salt Lake City company said market pressures and delays inshipping its new Series 9600 mobile C-arm may have affected itsfinancial numbers.

Despite the dip, OEC was profitable last year by a wide margin.Revenues for the year were $98.2 million, a drop of 1.8% overthe $100 million in sales recorded in 1993. Net income was $8.7million, 11% lower than the $9.8 million registered in the previousyear.

OEC president and CEO David Rose said the company experiencedshipping delays in the second quarter for Series 9600. In addition,the company's year-end backlog has decreased by about one-thirdover last year due to lengthening sales cycles and market pressures.Still, OEC is experiencing increased acceptance of Series 9600and the company has successfully reduced operating expenses, accordingto Rose.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.